10-03-2023, 06:48

FDA Advisory Committee votes in favour of the clinical

U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX
Globe Newswire10-03-2023, 06:48